Filtered By:
Management: Partnerships
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 1065 results found since Jan 2013.
Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
Roche and its subsidiary,TibMolbiol, confirm that it has tests for research use that identify the SARS-CoV-2subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World Health Organization (WHO) has recently reported that the BA.2subvariant is steadily increasing in prevalence, specifically in Denmark Use of these tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines and public health interventionsAll Roche SARS-Cov-2 tests correctly identify the virus including these newsubvariantsBasel, 16 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY)...
Source: Roche Investor Update - March 16, 2022 Category: Pharmaceuticals Source Type: news
Coronavirus (COVID-19) Infection Survey, UK: 11 March 2022, ONS (updated 11th March 2022)
This study is jointly led by the Office for National Statistics (ONS) and the Department for Health and Social Care (DHSC) working with the University of Oxford and Lighthouse laboratory to collect and test samples.
Source: Current Awareness Service for Health (CASH) - March 11, 2022 Category: Consumer Health News Source Type: news
Reshaping the Future: An Innovative Academic-Practice Collaboration for COVID-19 Vaccinations and Testing
The coronavirus disease-2019 (COVID-19) pandemic posed unprecedented challenges for health care organizations, schools of nursing, and surrounding communities. Health care organizations encountered rapidly changing guidelines and shortages in the health care workforce and critical medical supplies. Schools of nursing were responding to abrupt suspensions of clinical placements, uncertainties about the transmission of the novel virus, and shortages of personal protective equipment. Despite these challenges, health care organizations and schools of nursing were laser-focused on the need to ensure a competent nursing workforc...
Source: Nursing Administration Quarterly - March 7, 2022 Category: Nursing Tags: Original Articles Source Type: research
COVID-19 May Be Linked to Spontaneous Psychosis. Researchers Are Trying to Figure Out Why
In May 2020, a 33-year-old mother of three in North Carolina started experiencing symptoms of COVID-19. Four days later, a different set of symptoms set in. She stopped sleeping well and started having paranoid delusions that people were tracking her through her cell phone—culminating in a frantic scene at a fast-food restaurant, in which she tried to pass her children through the drive-through window, where they’d be safe from the phones and other dangers.
A restaurant employee called 911, and emergency medical services workers arrived, gathered up the family, and hurried to the nearby emergency department of...
Source: TIME: Health - March 4, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Sen. Tim Kaine, Who Has Long COVID, Introduces Bill to Help Long Haulers
U.S. Senator Tim Kaine is all too familiar with the harrowing effects of Long COVID. And on Wednesday, the Virginia Democrat introduced legislation to help other Americans struggling with the same mysterious illness.
Kaine was diagnosed with COVID-19 nearly two years ago, but still suffers from moderate symptoms. And he’s not alone. Thousands, potentially millions, of Americans have continued to cope with health concerns long after infection. Because more research is needed and diagnoses remain inconsistent, it’s hard to gauge just how many people are plagued by lingering effects of the virus.
The Comprehensive...
Source: TIME: Health - March 3, 2022 Category: Consumer Health News Authors: Madison Muller / Bloomberg Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news
Improving the health equity and the human rights of Canadians with dementia through a social determinants approach: a call to action in the COVID-19 pandemic
Can J Public Health. 2022 Mar 3:1-5. doi: 10.17269/s41997-022-00618-8. Online ahead of print.ABSTRACTIn 2019, the Canadian Government released a national dementia strategy that identified the need to address the health inequity (e.g., avoidable, unfair, and unjust differences in health outcomes) and improve the human rights of people living with dementia. However, the novel coronavirus disease 2019 (COVID-19) pandemic is having an inequitable impact on people with dementia in terms of mortality and human rights violations. As the new Omicron COVID-19 variant approaches its peak, our commentary highlights the need for urgen...
Source: Canadian Journal of Public Health - March 3, 2022 Category: International Medicine & Public Health Authors: Juanita-Dawne R Bacsu Megan E O'Connell Mary Beth Wighton Source Type: research
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and Care
The COVID-19 (coronavirus disease 2019) pandemic has worldwide implications on health care, especially in our most vulnerable population: cancer patients. Flexibility and adaptation are needed to continue clinical research and for clinical trial development. At the Intramural Research Program, National Cancer Institute, swift changes have been implemented to protect our patients while maintaining the scientific integrity of our cancer clinical trials. Many lessons have been learned including incorporation of telehealth into clinical trials, partnerships with the oncology community at both academic institutions and communit...
Source: The Cancer Journal - March 1, 2022 Category: Cancer & Oncology Tags: Review Articles Source Type: research
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine
The sudden emergence of the coronavirus disease 2019 (COVID-19) pandemic in early 2020 stimulated unprecedented scientific initiatives to rapidly develop effective treatments and vaccines. One example was the development of vaccines based on messenger RNA platforms, which received emergency use authorization in the United States less than 1 year after the primary sequence of the severe acute respiratory syndrome coronavirus 2 virus was published. Novel practices arose from the collaborative efforts and inclusive clinical studies that facilitated the vaccines' rapid development and clinical testing. I describe insights gain...
Source: The Cancer Journal - March 1, 2022 Category: Cancer & Oncology Tags: Review Articles Source Type: research
